A federal judge has recused himself from a UnitedHealthcare proton therapy lawsuit; researchers are trying to develop a lifetime flu vaccine; researchers create an inexpensive 3D printed microscope for medical diagnostics in developing countries.
Yesterday, US District Judge Robert Scola recused himself from deciding 1 of the 2 lawsuits against UnitedHealthcare that have been filed in the last 2 months over the company denying coverage for proton radiation therapy to patients with cancer, Kaiser Health News reported. Scola's recusal was due to his personal experience with the treatment. In an order of recusal, he wrote that denying a patient the treatment was "immoral and barbaric." Insurers have long been reluctant to pay for the treatment in the past. A new approach that teaches the body to identify a portion of the flu virus that remains unchanged could lead to a lifetime flu vaccine, according to MedicalXpress. While testing on lab animals has shown early signs of success, the vaccine needs to be made more specific and applied in larger studies before it can be tested on humans. The technique uses a protein that can bind to a precise spot on the flu virus, called a monoclonal antibody, to help the immune system target the unchanging protein of the virus and attack it.Researchers have printed a 3-dimension portable, high resolution microscope that is inexpensive and can be easily replicated, making it useful for medical diagnostics in developing countries, ScienceDaily reported. The microscope doesn’t require any special staining or labels and could potentially detect diseases such as malaria, sickle cell disease, diabetes, and others. The instrument could additionally be used in research, education, defense, and manufacturing. Researchers say that the device is ready for practical use and a reproduction could be made at a fraction of the price of similar microscopes.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More